A Study of MET233 in Individuals With Obesity or Overweight

PHASE1/PHASE2RecruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

October 24, 2025

Study Completion Date

January 3, 2026

Conditions

Obesity and Overweight

Interventions

BIOLOGICAL

MET233

For subcutaneous administration

BIOLOGICAL

Placebo

Sterile 0.9% (w/v) saline for subcutaneous administration

Trial Locations (1)

RECRUITING

MET233 Research Site 001, Cypress